Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.
Beskrivning
Osteoporosis, a growing epidemic among women in North America, Europe, and Japan, is a painful, costly disease that has presented a treatment challenge to healthcare professionals. Until recently, therapies have focused on agents that slow bone resorption, and have had only limited success at increasing bone mass.
Osteoporoses: Their Nature and Therapeutic Targets. Osteoporosis - Mechanisms and Models. PTH: Skeletal Effects in the Ovariectomized Rat Model for Postmenopausal Bone Loss. Parathyroid Hormone: The Clinical Experience and Prospects. Adenylyl Cyclase-Activating Anabolic Agents: Parathyroid Hormone and Prostaglandins E. Bone Formation May Be Uncoupled from Resorption, as Demonstrated by a New Class of hPTHrP-(1-34) Analogues in Both Rapid and Slow Turnover Models of Osteopenia. Commercial Exploitation of Parathyroid Hormone Therapy for the Treatment of Postmenopausal Osteoporosis. The Insulin-Like Growth Factors: Potential Anabolic Agents for the Skeleton. Osteogenic Actions of Fluoride: Its Therapeutic Use for Established Osteoporosis. Index.NTI/Sales Copy
